Phase 2 Trial of Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma
Phase 2 Trial of Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma
Active, not recruiting · NCT03097939 · Registry updated 2026-06-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 2 Trial of Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma | Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, carcinoma, epithelial neoplasm, nasopharyngeal carcinoma, nasopharyngeal disorder, nasopharyngeal neoplasm, neoplasm, otorhinolaryngologic disease | Active, not recruiting | Phase 2 | 2026-06-22 | NCT03097939 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cancer Centre, Singapore | 44 |
| National Taiwan University Hospital | 540 |
| National University of Singapore | 97 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| National Cancer Center Singapore | Singapore | Singapore | 3 |